Contents

CNS & Neurological Disorders - Drug Targets , Volume 6 - Number 3

Editorial [Hot Topic: Depression (Part 2) (Guest Editors: Ronald S. Duman and John H. Kehne)]

, 6(3): 161 - 162

Ronald S. Duman and John H. Kehne


DOI: 10.2174/187152707780619317




The CRF1 Receptor, a Novel Target for the Treatment of Depression, Anxiety, and Stress-Related Disorders

, 6(3): 163 - 182

John H. Kehne


DOI: 10.2174/187152707780619344




The Brain Galanin Receptors: Targets for Novel Antidepressant Drugs

, 6(3): 183 - 192

Xiaoying Lu, Lisa Sharkey and Tamas Bartfai


DOI: 10.2174/187152707780619335




Targeting Signal Transduction Pathways in the Treatment of Mood Disorders: Recent Insights into the Relevance of the Wnt Pathway

, 6(3): 193 - 204

Todd D. Gould, Eliot R. Dow, Kelley C. O'Donnell, Guang Chen and Husseini K. Manji


DOI: 10.2174/187152707780619308




Adult Hippocampal Neurogenesis as Target for the Treatment of Depression

, 6(3): 205 - 218

Michael R. Drew and Rene Hen


DOI: 10.2174/187152707780619353




Gliogenesis and Glial Pathology in Depression

, 6(3): 219 - 233

G. Rajkowska and J. J. Miguel-Hidalgo


DOI: 10.2174/187152707780619326




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science